William F. Fearon, MD

Country USA
Specialty Interventional Cardiologist
  1. Role of PCI in Multivessel CAD: What Do the New Guidelines Say?
  2. FFR-Guided PCI for Multivessel CAD in 2022
  3. Angiography-derived Coronary Physiology
  4. Complete Revascularization for MVD and LM: Anatomic or Functional Concept
  5. Angio-guided vs. FFR-guided PCI
  6. FAME III: The Lessons from FAME Studies, What We Learned
  8. Many Pressure Wires in Cath Lab: Advantages and Disadvantages
  9. FAME 2: 3-year Clinical and Cost-effectiveness Outcomes of FFR-guided PCI in Patients with Coronary Artery Disease
  10. Non-Invasive FFR Assessment
  11. FFR Is Still Standard!
  12. Is Anatomic Complete Revascularization Really Necessary?
  13. PCI vs. CABG in LM and MVD: Time to Apply FFR for Decision-Making: Updated Data and FAME-3
  14. Post-PCI FFR: What Does It Mean and Should We Measure It?
  15. Are We Ready to Move from FFR to Resting Indices?
  16. The FUTURE Trial and Current Evidence of FFR Guided PCI: Is There Warning Sign?
  17. Routine Assessment of the Microcirculation and Absolute Flow: A Glimpse to the Future
  18. FFR Is Underutilized - Beyond Just Intermediate Lesions!
  19. Left Main
  20. Coronary Blood Flow, Pressure and Resistance: How to Integrate, Interpret and Apply in Practice
  21. Update on FAME 3 Trial
  22. Who Needs Adenosine or iFR, I Have cFFR (Contrast FFR): Update on the CONTRAST Study
  23. Invasive Evaluation of the Patient with Chest Pain and No Obstructive CAD
  24. Integrated Use of IMR and FFR in Daily Practice
  25. The Ultimate: FAME 3
  26. FFR State-of-the-Art: Clinical Applications and New Technologies
  27. MVD and FAME Studies
  28. Practical Set-up
  29. Update of the FAME 3 Trial
  30. Experimental Basis and Clinical Validation of FFR
  31. Assessment and Clinical Relevance of Coronary Microvasculature
  32. For Ischemia, Forget VP and Focus on the Ischemic Lesion!
  33. [FFR Use at CathLab: More & Better] Unmet Need: FAME 3
  34. FFR Clinical Trials: Review and Update
  35. FFR Evaluation: Optimal Measurement and Common Mistakes
  36. Clinical Benefit of FFR
  37. Tips and Trick
  38. How to Integrate FAME I, FAME II and COURAGE?
  39. Importance of the Coronary Microvasculature
  40. FFR in Acute Coronary Syndrome: Culprit and Non-culprit Lesion
  41. FAME2 & COURAGE Trials: Going Functional, It\'s Solution!
  42. Update 2013: FFR-guided Decision Making
  43. Roles of FFR in Unstable Angina and NSTEMI
  44. Clinical Application of IMR : Evidence and Practice
  45. Sidebranch Compromise: Mechanism and Implication
  46. How and Why to Assess the Coronary Microvasculature
  47. Gap Between Anatomy and Function
  48. FFR Clinical Trials and Applications: Make the PCI Practice Changed
  49. Beyond FAME: The Integration of Invasive Ischemia Assessment(FFR) into Clinical Practice
  50. When to Use IVUS and When Would FFR Be a Better Choice?
  51. FFR Guided PCI
  52. Integrated Decision Making in Bifurcation Lesion (IVUS vs. FFR)
  53. Practice Guideline for FFR Use (FAME Study)
  54. FFR in Multivessel Disease: Results of the F.A.M.E. Multicenter, International, Randomized Study Comparing FFR Guided PCI to Angio Guided PCI in Patients with Multivessel CAD
  55. Fundamentals, Techniques, Pitfalls, and Limitations of FFR Interpretation and Measurement
  56. Fractional Flow Reserve: Concept and Practical Set Up
  57. FFR-Guided PCI
  58. FFR in Multivessel Disease: Results of the F.A.M.E. Multicenter, International, Randomized Study Comparing FFR guided PCI to Angio guided PCI in Patients with Multivessel CAD
  59. Physiologic Assessment of Coronary Microvascular Dysfunction
  60. Physiologic Study and PCI